Emtrix launch in Southeast Asia initiated in Malaysia
Posted: 14 November 2014 |
Moberg Pharma’s partner in Southeast Asia and China, Menarini APAC, has initiated the launch in Malaysia of Moberg Pharma’s prescription-free treatment for nail fungus…
Moberg Pharma’s partner in Southeast Asia and China, Menarini APAC, has initiated the launch in Malaysia of Moberg Pharma’s prescription-free treatment for nail fungus. The product is launched under Moberg’s brand Emtrix®
“During this week I had the pleasure of following the launch preparations on site in Southeast Asia when visiting the head office of Menarini APAC. It will be very exciting to follow the response in the market in Malaysia – our first market in the region. The growth potential for our brand in Southeast Asia and China is significant”, says Peter Wolpert, CEO of Moberg Pharma.
